(Q38977150)

8 September 2017

1 reference

title

Metabolically healthy obesity across the life course: epidemiology, determinants, and implications (English)

1 reference

8 September 2017

0 references

Catherine M. Phillips

object named as

Catherine M Phillips

series ordinal

1

0 references

language of work or name

English

0 references

publication date

10 October 2016

1 reference

Annals of the New York Academy of Sciences

8 September 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

volume

1391

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

85-100

1 reference

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Global burden of obesity in 2005 and projections to 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Trends and prevalence of overweight and obesity in primary school aged children in the Republic of Ireland from 2002-2012: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Evidence that the prevalence of childhood overweight is plateauing: data from nine countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Childhood obesity, other cardiovascular risk factors, and premature death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Childhood obesity affects adult metabolic syndrome and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Fetal origins of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Fetal programming and adult health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Physical activity and screen time in metabolically healthy obese phenotypes in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Clinical Characteristics and Metabolic Health Status of Obese Korean Children and Adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Predictors of metabolically healthy obesity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Insulin-sensitive obese children display a favorable metabolic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Cardiometabolic Health in Obese Adolescents Is Related to Length of Obesity Exposure: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Strong effect of pubertal status on metabolic health in obese children: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

High risk vs. "metabolically healthy" phenotype in juvenile obesity - neck subcutaneous adipose tissue and serum uric acid are clinically relevant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Do rapid BMI growth in childhood and early-onset obesity offer cardiometabolic protection to obese adults in mid-life? Analysis of a longitudinal cohort study of Danish men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Identification of Genetic and Environmental Factors Predicting Metabolically Healthy Obesity in Children: Data From the BCAMS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity: definitions, determinants and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Can we identify metabolically healthy but obese individuals (MHO)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Defining metabolically healthy obesity: role of dietary and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity: different prevalences using different criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Comparison of Metabolic Characteristics of Metabolically Healthy but Obese (MHO) Middle-Aged Men According to Different Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Assessing cardiometabolic risk in middle-aged adults using body mass index and waist-height ratio: are two indices better than one? A cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Overproduction of large VLDL particles is driven by increased liver fat content in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Abdominal obesity and fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Insulin-sensitive obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Preadipocyte factor-1 is associated with metabolic profile in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Does inflammation determine metabolic health status in obese and nonobese adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Body fat distribution and risk of cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically normal obese people are protected from adverse effects following weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Diet composition and activity level of at risk and metabolically healthy obese American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically Healthy Obesity Is Not Associated with Food Intake in White or Black Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Dysmetabolic Signals in "Metabolically Healthy" Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The Relationship between Dietary Patterns and Metabolic Health in a Representative Sample of Adult Australians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Effects of weight loss among metabolically healthy obese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy but obese women: effect of an energy-restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Effects of two-months balanced diet in metabolically healthy obesity: lipid correlations with gender and BMI-related differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Physical fitness during adolescence and adult mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Role of Fitness in the Metabolically Healthy but Obese Phenotype: A Review and Update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Prevalence, Risk Factors, and Genetic Traits in Metabolically Healthy and Unhealthy Obese Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Genetic Effects on Longitudinal Changes from Healthy to Adverse Weight and Metabolic Status – The HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Predicting the development of the metabolically healthy obese phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Improved metabolic health among the obese in six population surveys 1986 to 2009: the Northern Sweden MONICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

All-cause mortality risk of metabolically healthy obese individuals in NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically Healthy Obesity: Personalised and Public Health Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Is it finally time to dispel the concept of metabolically-healthy obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Is the metabolically healthy obesity phenotype an irrelevant artifact for public health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Obesity or obesities? Controversies on the association between body mass index and premature mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Does Metabolically Healthy Obesity Exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Whether all obese subjects both in metabolic groups and non-metabolic groups should be treated or not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Physical Activity and Sedentary Behavior in Metabolically Healthy versus Unhealthy Obese and Non-Obese Individuals - The Maastricht Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Proinflammatory and lipid biomarkers mediate metabolically healthy obesity: A proteomics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/public

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Depressive symptoms, anxiety and well-being among metabolic health obese subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Childhood Obesity and Vascular Phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

Leptin Receptor Polymorphisms Interact with Polyunsaturated Fatty Acids to Augment Risk of Insulin Resistance and Metabolic Syndrome in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13230

21 January 2018

Identifiers

DOI

10.1111/NYAS.13230

1 reference

8 September 2017

1 reference